In the Spotlight

Win the Cell & Gene Therapy Race with AGC Biologics

 

Amplify your career. Make an impact.

1 min read

BIO Asia-Taiwan, July 27-31, 2022

Date: July 27-31, 2022
Location: Taipei, Taiwan
Event Website: www.bioasiataiwan.com
Organizer: BIO and Taiwan BIO

 

Meet with our Team Members

 

Contact us to schedule a meeting

 

About our Biologics Services

AGC Biologics has successfully manufactured more than 200 biological projects for pre-clinical studies through commercial approvals. Our global facilities span three continents and offer multiple cGMP manufacturing lines at a variety of scales for mammalian cell culture and microbial fermentation.

Learn more about our cGMP manufacturing and capabilities

 

About our Cell & Gene Therapy Services

We develop and manufacture diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, depending on client needs. We also develop and manufacture adeno-associated​ viral vectors, lenti viral vectors and retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. 

Learn more about our Cell Therapy and Viral Vector services

 

Related Resources

Fact Sheets:

 

About the Event

BIO Asia–Taiwan 2022 Onsite + Online will showcase Taiwan's growing digital advantage in the biomed sector and spotlight biotech, pharmaceutical, medical devices, precision medicine advances, as well as AI applications, ICT and IoT technologies, and new healthcare/medical investment opportunities.